Module 4: Osteosarcoma and Condrosarcoma
Available from February 2027
Module 4: Osteosarcoma and Condrosarcoma
Available from February 2027
01/02/2027
Osteosarcoma: state of the art in the new WHO classification
01/02/2027
Benign and malignant chondroid tumors
01/02/2027
Surgical treatment of osteosarcoma
01/02/2027
Surgical treatment of cartilage tumors
01/02/2027
Chemotherapy in the treatement of osteosarcoma
01/02/2027
Chemotherapy and IDH1 target in chondrosarcoma
01/02/2027
Phase I trial in osteosarcoma and chondrosarcoma: the MDACC experience
01/02/2027
DR5 in chondrosarcoma: from clinical trial to approval path
01/02/2027
Drug development in osteosarcoma and chondrosarcoma: the Chinese perspective
01/02/2027
Stereotatic Radiotherapy for lung metastasese in chodrosarcoma and osteosarocma
01/02/2027
Genomic landscape and clinical application for osteosarcoma: the COG experience
01/02/2027
Dedifferentiated chodrosarcoma: chemotherapy and immunecheckpoint inhibitors
01/02/2027
Osteosarcoma TME: state of the art
01/02/2027
Lung metastasectomy do and don'ts: osteosarcoma and chondrosarcoma
01/02/2027
Clinical case discussion (live online session)
Module director: Palmerini Emanuela, IT/USA
